<?xml version="1.0" encoding="UTF-8"?>
<entry>
	<accession>DI1000316</accession>
	<general>
		<name>Autoinhibitory region bound to p21-activated kinase 4 (PAK4) kinase domain</name>
		<pdb_id>4l67</pdb_id>
		<exp_method>X-ray</exp_method>
		<resolution>2.80</resolution>
		<source_organism>Homo sapiens</source_organism>
		<disorder_status>Inferred from homology</disorder_status>
		<publication>
			<pmid>23876315</pmid>
			<authors>Wang W, Lim L, Baskaran Y, Manser E, Song J</authors>
			<title>NMR binding and crystal structure reveal that intrinsically-unstructured regulatory domain auto-inhibits PAK4 by a mechanism different for that of PAK1.</title>
			<journal>Biochem. Biophys. Res. Commun.</journal>
			<year>2013</year>
			<abstract>Six human PAK members are classified into groups I (PAKs 1-3) and II (PAK4-6). Previously, only group I PAKs were thought to be auto-inhibited but very recently PAK4, the prototype of group II PAKs, has also been shown to be auto-inhibited by its N-terminal regulatory domain. However, the complete auto-inhibitory domain (AID) sequence remains undefined and the mechanism underlying its auto-inhibition is largely elusive. Here, the N-terminal regulatory domain of PAK4 sufficient for auto-inhibiting and binding Cdc42/Rac was characterized to be intrinsically unstructured, but nevertheless we identified the entire AID sequence by NMR. Strikingly, an AID peptide was derived by deleting the binding-unnecessary residues, which has a Kd of 320nM to the PAK4 catalytic domain. Consequently, the PAK4 crystal structure complexed with the entire AID has been determined, which reveals that the complete kinase cleft is occupied by 20 AID residues composed of an N-terminal α-helix and a previously-identified pseudosubstrate motif, thus achieving auto-inhibition. Our study reveals that PAK4 is auto-inhibited by a novel mechanism which is completely different from that for PAK1, thus bearing critical implications for design of inhibitors specific for group II PAKs.</abstract>
		</publication>
	</general>
	<function>
		<molecular_function>
			<go>
				<accession>GO:0004674</accession>
				<name>protein serine/threonine kinase activity</name>
			</go>
			<go>
				<accession>GO:0005524</accession>
				<name>ATP binding</name>
			</go>
			<go>
				<accession>GO:0048365</accession>
				<name>Rac GTPase binding</name>
			</go>
			<go>
				<accession>GO:0098641</accession>
				<name>cadherin binding involved in cell-cell adhesion</name>
			</go>
		</molecular_function>
		<biological_process>
			<go>
				<accession>GO:0006915</accession>
				<name>apoptotic process</name>
			</go>
			<go>
				<accession>GO:0007049</accession>
				<name>cell cycle</name>
			</go>
			<go>
				<accession>GO:0007266</accession>
				<name>Rho protein signal transduction</name>
			</go>
			<go>
				<accession>GO:0007346</accession>
				<name>regulation of mitotic cell cycle</name>
			</go>
			<go>
				<accession>GO:0008283</accession>
				<name>cell proliferation</name>
			</go>
			<go>
				<accession>GO:0016049</accession>
				<name>cell growth</name>
			</go>
			<go>
				<accession>GO:0016477</accession>
				<name>cell migration</name>
			</go>
			<go>
				<accession>GO:0023014</accession>
				<name>signal transduction by protein phosphorylation</name>
			</go>
			<go>
				<accession>GO:0030036</accession>
				<name>actin cytoskeleton organization</name>
			</go>
			<go>
				<accession>GO:0031098</accession>
				<name>stress-activated protein kinase signaling cascade</name>
			</go>
			<go>
				<accession>GO:0032147</accession>
				<name>activation of protein kinase activity</name>
			</go>
			<go>
				<accession>GO:0042981</accession>
				<name>regulation of apoptotic process</name>
			</go>
			<go>
				<accession>GO:0043408</accession>
				<name>regulation of MAPK cascade</name>
			</go>
			<go>
				<accession>GO:0060996</accession>
				<name>dendritic spine development</name>
			</go>
			<go>
				<accession>GO:0071407</accession>
				<name>cellular response to organic cyclic compound</name>
			</go>
			<go>
				<accession>GO:0098609</accession>
				<name>cell-cell adhesion</name>
			</go>
		</biological_process>
		<cellular_component>
			<go>
				<accession>GO:0005794</accession>
				<name>Golgi apparatus</name>
			</go>
			<go>
				<accession>GO:0005913</accession>
				<name>cell-cell adherens junction</name>
			</go>
			<go>
				<accession>GO:0005925</accession>
				<name>focal adhesion</name>
			</go>
		</cellular_component>
	</function>
	<macromolecules>
		<general>
			<note>No modifications of the original PDB file.</note>
			<nr_of_chains>2</nr_of_chains>
			<domain_type>Protein kinase</domain_type>
		</general>
		<chain>
			<id>B</id>
			<name>Serine/threonine-protein kinase PAK 4</name>
			<type>Disordered</type>
			<source_organism>Homo sapiens</source_organism>
			<sequence>PRQWQSLIEESARRPKPLVDPACIT</sequence>
			<length>25</length>
			<uniprot>
				<id>O96013</id>
				<start>36</start>
				<end>60</end>
				<coverage>4.2%</coverage>
			</uniprot>
			<uniref90>
				<id>UniRef90_O96013</id>
				<start>36</start>
				<end>60</end>
			</uniref90>
			<regions>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>42</region_start>
					<region_end>45</region_end>
				</region>
				<region>
					<region_type>pfam</region_type>
					<region_id>PF00786.25</region_id>
					<region_name>PBD</region_name>
					<region_start>10</region_start>
					<region_end>66</region_end>
				</region>
			</regions>
		</chain>
		<chain>
			<id>A</id>
			<name>Serine/threonine-protein kinase PAK 4</name>
			<type>Ordered</type>
			<source_organism>Homo sapiens</source_organism>
			<sequence>SHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPASIVPLMRQNRTR</sequence>
			<length>292</length>
			<uniprot>
				<id>O96013</id>
				<start>300</start>
				<end>591</end>
				<coverage>49.4%</coverage>
			</uniprot>
			<uniref90>
				<id>UniRef90_O96013</id>
				<start>300</start>
				<end>591</end>
			</uniref90>
			<regions>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>301</region_start>
					<region_end>309</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>317</region_start>
					<region_end>319</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>321</region_start>
					<region_end>326</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>335</region_start>
					<region_end>340</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>346</region_start>
					<region_end>353</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>362</region_start>
					<region_end>368</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>378</region_start>
					<region_end>378</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>381</region_start>
					<region_end>387</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>390</region_start>
					<region_end>395</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>401</region_start>
					<region_end>402</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>403</region_start>
					<region_end>407</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>414</region_start>
					<region_end>433</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>437</region_start>
					<region_end>437</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>443</region_start>
					<region_end>445</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>446</region_start>
					<region_end>448</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>454</region_start>
					<region_end>456</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>463</region_start>
					<region_end>463</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>472</region_start>
					<region_end>472</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>479</region_start>
					<region_end>481</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>484</region_start>
					<region_end>487</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>beta</region_name>
					<region_start>492</region_start>
					<region_end>492</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>496</region_start>
					<region_end>510</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>520</region_start>
					<region_end>529</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>538</region_start>
					<region_end>540</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>543</region_start>
					<region_end>550</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>563</region_start>
					<region_end>566</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>570</region_start>
					<region_end>574</region_end>
				</region>
				<region>
					<region_type>secondary structure</region_type>
					<region_name>helix</region_name>
					<region_start>578</region_start>
					<region_end>584</region_end>
				</region>
				<region>
					<region_type>pfam</region_type>
					<region_id>PF00069.22</region_id>
					<region_name>Pkinase</region_name>
					<region_start>321</region_start>
					<region_end>572</region_end>
				</region>
			</regions>
		</chain>
	</macromolecules>
	<evidence>
		<chain_evidence>
			<chain_id>B</chain_id>
			<support>The interacting region of PAK4 has been shown to be intrinsically disordered in homologous proteins (PMID:9660763 and PMID:15821030). The 65-123 region described in IDEAL entry IID50053 covers 60% of the binding sequence in a homologous protein.</support>
		</chain_evidence>
		<chain_evidence>
			<chain_id>A</chain_id>
			<support>The protein kinase domain involved in the interaction is known to adopt a stable structure in isolation (see Pfam domain PF00069). A solved monomeric structure of the domain is represented by PDB ID 1i09.</support>
		</chain_evidence>
	</evidence>
	<related_structures>
		<pdb_id>4fie</pdb_id>
		<pdb_id>4fif</pdb_id>
		<pdb_id>4fii</pdb_id>
	</related_structures>
</entry>
